Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Its documented receptor binding affinity and metabolic stability give it a defined position as a reference tool
The company is advancing next-generation oral and injectable treatments and raised $411M in an oversubscribed Series A round, co-led by Forbion and General Atlantic, with participation from RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures, and LYFE Capital
Xue, X.-C., Wu, Y.-J., Gao, M.-T., Li, W.-G., Zhao, N., Wang, Z.-L., Bao, C.-J., Yan, Z., & Zhang, Y.-Q
Preconception paternal alcohol exposure exerts sex-specific effects on offspring growth and long-term metabolic programming
US$ 26.14
US$ 29.38
US$ 21.96
US$ 22.42
US$ 27.99
US$ 27.30
US$ 28.78
